Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Damien Barnette, one of the Postdoctoral Research Scientists here in the department has recently published new data in the journal JCI Insight, iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction.

When the heart undergoes injury, such as following a heart attackan immediate response is the infiltration of immune cells of which one important sub-type are macrophages. These are thought to come in two distinct “flavours”- early “proinflammmatory” (or M1), which mop up dead and dying cells, followed by “reparative” (M2) macrophages, which help remodel the heart and contribute to patching the area of injury with a scar.

By looking at the injured hearts in mice that lack secretion of a key inflammatory molecule called TNF-alpha from their macrophages, Dr Barnette and colleagues revealed an unexpected link between the two immune cell phases in response to injury.

The dampening of pro-inflammatory signalling had a direct, knock-on effect on scar formation, whereby the mutant mice had less stable scars, poor heart function and reduced survival.

This suggests that there is a gradient of immune cell responses which is not restricted to the two “flavours”, and that downstream repair of a heart attack by scar formation is inextricably linked to the early pro-inflammatory immune cell response. This has important implications for designing strategies to modulate inflammation and repair as a combined therapy with restoring lost cardiovascular tissue after heart attack.

This work was done in collaboration with Professor Paul RileyDr Thomas CahillMs Mala Gunadasa-Rohling, Professor Carolyn Carr, Professor Matthew Freeman (Dunn School) and was supported by the British Heart Foundation

To find out more about the research that goes on at DPAG similar to this, visit the Riley Research Group webpage.

Similar stories

REF 2021 results

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.

Oxford Parkinson’s Disease Centre awarded £3.8 million to reveal the role of calcium in Parkinson’s

A collaborative research team led by the Oxford Parkinson’s Disease Centre (OPDC) has been awarded a £3.8 million Wellcome Trust Collaborative Award to study the function of calcium in dopamine neurons, and how this is plays a role in Parkinson’s. Their research will help explain how and why dopamine neurons are vulnerable in the disease and look at how they may be preserved.

DPAG Postdoctoral Researcher acknowledged for developmental and cell biology research

Dr Matthew Stower was selected to give an oral presentation of his work and his abstract won the second prize at the Joint Spring Meeting of the British Society for Developmental Biology (BSDB) and the British Society for Cell Biology (BSCB).

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.